<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thirty patients with <z:hpo ids='HP_0011009'>acute</z:hpo> severe lower limb arterial obstruction were treated with local administration of low dose Urokinase associated with <z:chebi fb="0" ids="32568">Lysyl</z:chebi> Plasminogen </plain></SENT>
<SENT sid="1" pm="."><plain>Fifty-three per cent primary and 40 p </plain></SENT>
<SENT sid="2" pm="."><plain>100 secondary successes were obtained with few complications but one <z:hpo ids='HP_0011420'>death</z:hpo> due to <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> related to the catheterisation procedure </plain></SENT>
<SENT sid="3" pm="."><plain>This intra-arterial therapeutic association seems to be as effective as local streptokinase infusion, but it is much better tolerated than other forms of treatment </plain></SENT>
<SENT sid="4" pm="."><plain>It could be the treatment of choice in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0005315'>occlusive arterial disease</z:hpo> of the lower limbs providing the therapeutic indications are strictly respected </plain></SENT>
</text></document>